Scientific Company Directory
The latest research, products, and discoveries from the science industry’s leading companies and company divisions.
Scientific Products
From innovative tools to essential equipment and supplies, find everything you need to advance your research on our new Scientific Products page.
Search Scientific ProductsSanta Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.
The Sartorius Group is a leading international partner of biopharmaceutical research and the industry. With innovative laboratory instruments and consumables, the Group's Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently.
About Phenomenex
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in academic, pharmaceutical, biotech, environmental, clinical research, government, and industrial laboratories. From drug discovery and pharmaceutical development to food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve human health and well-being. Phenomenex is an operating company within the Life Sciences group of Danaher Corporation.
For more information, please visit www.phenomenex.com and follow the company's blog at www.scienceunfiltered.com
Leica Biosystems is a global leader in Anatomical Pathology solutions and automation, striving to advance cancer diagnostics to improve patients' lives. Leica Biosystems provides Pathologists, Histologists, and Researchers a comprehensive range of products for each step in the Pathology process. From specimen preparation and staining to imaging and reporting, our solutions help increase workflow efficiencies meaning patients receive their results sooner. Slide after slide, Leica's easy-to-use and consistently reliable offerings provide you with the diagnostic clarity you need to give patients the results that they can trust.
For over 55 years, INFORS HT has been developing and producing high-tech solutions for biotechnology, biopharmaceuticals, food technology, agricultural technology, and research institutes worldwide. Our areas of competence cover the entire culture process, from screening to process development to production. We are proud to be one of the best in the field of specialists for bioreactors, shaker incubators and bioprocess control software. Much has changed since the company was founded in 1965. The Spirit of INFORS HT, however, remains the same. In keeping with our company creed— "We firmly believe you can make anything better"—we commit ourselves every day to simplifying our biotechnology customers' workflows using the most modern technologies available.
Olink® Proteomics, part of Thermo Fisher Scientific is a global biotechnology company dedicated to providing advanced products and services that enable new discoveries into human health and disease. Olink's innovative solutions deliver highly sensitive, precise, and multiplexed protein quantification, giving scientists the power to investigate complex biological processes with precision.
Trusted by leading academic institutions and top pharmaceutical companies worldwide, Olink is committed to supporting researchers globally in their pursuit of improving human health. Headquartered in Uppsala, Sweden, Olink has offices in North America, Asia, and Europe.
Centrifuges. Particle counters/analyzers. Automated and acoustic liquid handlers. Flow cytometers. Genomic reagents. All these products, and many more, continue to make a difference in people's lives-by improving the productivity of scientists dedicated to discovering new and better disease therapies.
An operating company of Danaher Corporation (NYSE: DHR) since 2011, Beckman Coulter Life Sciences has more than 3,400 global associates, each committed to empowering those seeking answers to life's important scientific and healthcare questions. For details, visit beckman.com.
Sapio Sciences' mission is to improve lives by accelerating discovery, and because science is complex, Sapio makes technology simple. Sapio is a global business offering an all-in-one science-aware (TM) lab informatics platform combining cloud-based LIMS, ELN, and Jarvis data solutions.
Sapio serves some of the largest global and specialist brands, including biopharma, CRO/CDMOs and clinical diagnostic labs across NGS genomic sequencing, bioanalysis, bioprocessing, chemistry, stability, histopathology, and in vivo studies.
Customers love Sapio's platform because it is robust, scalable, and with no-code configuration, can quickly adapt to meet unique needs. For more information, visit www.sapiosciences.com and follow us on LinkedIn.
At Stago, we work with you to design a comprehensive hemostasis solution to fit the unique needs of your laboratory. Our unique approach focuses on improving patient outcomes and reducing the overall cost of care. Rest assured with reliable results from our standardized testing platforms. Expert support services combined with a complete menu of routine and specialty assays enable you to focus on your patients while we focus on you.
At MaxCyte, we share your passion for the discovery, development, and manufacturing of next generation therapies, harnessing the power of living cells to transform lives.
We know that every research journey is full of challenges, but we believe that transfecting cells shouldn’t be one of them. With over 20 years of cell engineering expertise using our best-in-class electroporation technology, we’ve perfected the art of the cell-engineering workflow. We want to share this with you to enable your pioneering research and help you to chart your most direct course to success.
MaxCyte is the technology of choice for cell-engineering experts, driving a new generation of cell-based therapies. We have collaborated in many clinical trials driven by leaders in pharma and biotech to develop treatments for an expanding range of indications, including cancer, central nervous system disorders, and rare genetic diseases.
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
BioLegend develops world-class, cutting-edge antibodies, recombinant proteins, bioassays, and other reagents for biomedical research, manufactured in our state-of-the-art facility in San Diego, California. Our mission is to accelerate research and discovery by providing the highest quality products at an outstanding value, along with superior customer service and technical support. BioLegend was incorporated in June, 2002. The founder and CEO of BioLegend, Gene Lay, D.V.M., who was also the co-founder of PharMingen.
Illumina is transforming human health as the global leader in sequencing and array-based technologies. Illumina's flexible and scalable sequencing systems support and enable a wide range of single-cell sequencing applications, from low-throughput deep interrogation of rare cell populations to high-throughput profiling of tissues. For more information, please visit www.illumina.com.
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues serve people in more than 160 countries.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure.
Revvity is pushing the limits of what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
With a robust global network and localized agility, we serve a diverse range of organizations from pharmaceutical and biotech, to clinical labs, academia, and governments.
Together with our customers and partners, we are united in impact, embracing the impossible to improve lives everywhere.
Sebia is the world's leading provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic (IVD) testing. Its systems analyze proteins in order to screen and monitor various diseases and conditions; primarily oncology (Multiple Myeloma), metabolic disorders such as Diabetes and also Hemoglobinopathy and rare pathologies.
Covaris provides tools and technologies to improve pre-analytical sample preparation, enable novel drug formulations, and manage compounds in the drug discovery process.
The Covaris technological foundation is based on its proprietary and patented AFA™ technology. AFA enables a vast array of non-contact, isothermal processes to be developed for use in a broad range of applications in Genomics, Proteomics, Cell Biology and Drug Discovery, and Formulation. Thousands of Focused-ultrasonicators are in use in over 30 countries and customers include the world’s leading researchers, universities, and pharmaceutical companies.
Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision-making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, drug response prediction, and development of companion diagnostics.
The HORIBA Group of worldwide companies provides an extensive array of instruments and systems for applications ranging from automotive R&D, process and environmental monitoring, in-vitro medical diagnostics, semiconductor manufacturing and metrology, to a broad range of scientific R&D and QC measurements. Proven quality and trustworthy performance have established widespread confidence in the HORIBA Brand.
DiaSorin Molecular LLC manufactures and distributes molecular diagnostic products worldwide. Our Simplexa® molecular kits include HSV 1 & 2, Flu A/B & RSV, COVID-19, Bordetella, VZV, Group A Strep, GBS, C. difficile and our latest: SARS-CoV-2 Variants (RUO)*. Additionally, our menu includes over 65 primer pairs for laboratory developed tests. Simplexa® products are designed for use on the LIAISON® MDX, a real-time PCR instrument, which has the capability of running either an 8 well or 96 well disc. This provides an ideal platform to accommodate all volume testing needs. *For Research Use Only. Not for use in diagnostic procedures.
Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific. Today, over 300,000 customers from over 160 countries and regions around the world have used GenScript’s premier, convenient, and reliable products and services. GenScript currently has more than 5,000 employees globally, 33% of whom hold master’s and/or Ph.D. degrees. In addition, GenScript has a number of leading commercial technologies developed in the fields of synthetic biology, immunotherapy, antibody design, chemical synthesis and bioinformatics, including more than 100 patents and over 270 patent applications. As of June 2022, GenScript's products and services have been cited by 74,700 scientific papers worldwide. GenScript is committed to striving toward its vision of being the most reliable biotech company in the world to make humans and nature healthier through biotechnology.